Further evaluation of the hormonal profile of the metastatic tumor demonstrated strong and diffuse reactivity for estrogen receptor (ER) and progesterone receptor (PR) with equivocal staining for human epidermal growth factor receptor 2 (HER2) and a Ki-67 proliferation index of 10 % (Fig. 2). The gene discussed is ERBB2; the disease is neoplasm.